Abstract:Using an unbiased high-throughput microRNA (miRNA)-silencing screen combined with functional readouts for mitochondrial oxidative capacity in C2C12 myocytes, we previously identified 19 miRNAs as putative regulators of skeletal muscle mitochondrial metabolism. In the current study, we highlight miRNA-204-5p, identified from this screen, and further studied its role in the regulation of skeletal muscle mitochondrial function. Following silencing of miRNA-204-5p in C2C12 myotubes, gene and protein expression were assessed using quantitative polymerase chain reaction, microarray analysis, and western blot analysis, while morphological changes were studied by confocal microscopy. In addition, miRNA-204-5p expression was quantified in human skeletal muscle biopsies and associated with in vivo mitochondrial oxidative capacity. Transcript levels of PGC-1 alpha (3.71-fold; p < .01), predicted as an miR-204-5p target, as well as mitochondrial DNA copy number (p < .05) and citrate synthase activity (p = .06) were increased upon miRNA-204-5p silencing in C2C12 myotubes. Silencing of miRNA-204-5p further resulted in morphological changes, induced gene expression of autophagy marker light chain 3 protein b (LC3B; q = .05), and reduced expression of the mitophagy marker FUNDC1 (q = .01). Confocal imaging revealed colocalization between the autophagosome marker LC3B and the mitochondrial marker OxPhos upon miRNA-204-5p silencing. Finally, miRNA-204-5p was differentially expressed in human subjects displaying large variation in oxidative capacity and its expression levels associated with in vivo measures of skeletal muscle mitochondrial function. In summary, silencing of miRNA-204-5p in C2C12 myotubes stimulated mitochondrial biogenesis, impacted on cellular morphology, and altered expression of markers related to autophagy and mitophagy. The association between miRNA-204-5p and in vivo mitochondrial function in human skeletal muscle further identifies miRNA-204-5p as an interesting modulator of skeletal muscle mitochondrial metabolism.

MicroRNA-27b Regulates Mitochondria Biogenesis in Myocytes.

MicroRNA: A New Mechanism for Regulation of Mitochondrial Function

Role of Microrna-27a in Myoblast Differentiation

MicroRNA-27a promotes myoblast proliferation by targeting myostatin.

miR-27b overexpression improves mitochondrial function in a Sirt1-dependent manner

Microrna133a Targets Foxl2 and Promotes Differentiation of C2C12 into Myogenic Progenitor Cells.

MicroRNA-204-5p modulates mitochondrial biogenesis in C2C12 myotubes and associates with oxidative capacity in humans.

MiRNA-199a-3p Regulates C2C12 Myoblast Differentiation through IGF-1/AKT/mTOR Signal Pathway

MicroRNA-27a is induced by leucine and contributes to leucine-induced proliferation promotion in C2C12 cells.

Effects of MicroRNA-27a on Myogenin Expression and Akt/FoxO1 Signal Pathway during Porcine Myoblast Differentiation.

Mir-25 Protects Cardiomyocytes Against Oxidative Damage By Targeting The Mitochondrial Calcium Uniporter

Cardiomyocyte Overexpression of Mir-27B Induces Cardiac Hypertrophy and Dysfunction in Mice.

MicroRNA‑23a‑5p Mediates the Proliferation and Differentiation of C2C12 Myoblasts.

Mir-10b-5p Regulates C2c12 Myoblasts Proliferation And Differentiation

Effect Of Mir-143-3p On C2c12 Myoblast Differentiation

MicroRNA Directly Enhances Mitochondrial Translation During Muscle Differentiation.

MicroRNA, Mir-374B, Directly Targets Myf6 and Negatively Regulates C2C12 Myoblasts Differentiation.

miR-152 regulates the proliferation and differentiation of C2C12 myoblasts by targeting E2F3

Mir-103-3p Regulates the Differentiation and Autophagy of Myoblasts by Targeting MAP4

Mir-378A-3p Promotes Differentiation and Inhibits Proliferation of Myoblasts by Targeting HDAC4 in Skeletal Muscle Development.

Mir-324-5p Inhibits C2C12 Cell Differentiation and Promotes Intramuscular Lipid Deposition Through Lncdum and PM20D1